Repligen alleges BMS arthritis drug infringes patent
The patent covers methods of using CTLA4-Ig to treat rheumatoid arthritis, as well as other therapeutic methods. The FDA approved Bristol Myers Squibb’s (BMS’) application to market CTLA4-Ig,
The patent covers methods of using CTLA4-Ig to treat rheumatoid arthritis, as well as other therapeutic methods. The FDA approved Bristol Myers Squibb’s (BMS’) application to market CTLA4-Ig,
Cancer is the second leading cause of death in the US. It has been estimated that approximately one-half of all men and one-third of all women will develop
In the last five years researchers have been examining the genes expressed during breast cancer in order to classify those genes into groups that can reliably predict the
Scientists at the University of Rochester Medical Center have demonstrated that star-shaped brain cells known as astrocytes play a direct role in controlling blood flow in the brain,
The new agreement will extend the alliance for up to three years with a guaranteed minimum number of targets to be supplied by Athersys annually. Under the terms
Hepatitis C always recurs after liver transplantation, often damaging the new organ and rendering patients ineligible for retransplantation. Patients commonly use interferon-ribavirin combination therapy to combat the hepatitis
“Currently, there is no commercially available adjunctive injectable therapy, outside of a hospital setting, for the emergency treatment of acute repetitive epileptic seizures,” said Michael Jolly, executive vice
In the largest study of its kind, the researchers found smoking during pregnancy significantly elevates the risk of having a child with excess, webbed or missing fingers and
Liver disease is often associated with ‘sickness behaviors’, such as malaise, listlessness, anorexia, difficulty concentrating and fatigue. In cholestatic liver diseases (where bile production is impaired) fatigue occurs
VAX100 is a BCR-ABL peptide vaccine designed to reduce persistent disease in patients with chronic myeloid leukemia (CML) who have had stable disease during conventional therapy. The study